CMS proposes Medicare Advantage rule to expand food and plan competition
The proposed Contract Year 2028 rule, issued Nov. 20, would set a Dietary Guidelines-based standard for food benefits and launch a mandatory 10-year Innovation Center model in select states.
. 3-minute read.

The Centers for Medicare & Medicaid Services issued a proposed rule on Nov. 20 that would revise Medicare Advantage, Part D and PACE for contract year 2028, according to a CMS fact sheet. The rule, CMS-4214-P2, would set a Dietary Guidelines-based definition of healthy food for supplemental benefits, create the first mandatory Medicare Advantage model from the CMS Innovation Center, simplify Star Ratings and loosen certain network adequacy requirements.
In a press release, HHS Secretary Robert F. Kennedy Jr. said, “Medicare food benefits should pay for nutritious food that helps people improve their health and manage chronic disease.” CMS Administrator Dr. Mehmet Oz said the proposals are about “creating a Medicare Advantage marketplace that rewards better care and better value.” CMS Innovation Center Director Abe Sutton said the mandatory model “can help people with Medicare Advantage get more transparent, high-value care that meets their specific conditions and situation.”
The proposal would require food and beverage supplemental benefits to meet a standard based on the 2025–2030 Dietary Guidelines for Americans, meaning they would have to be whole and nutrient-dense. Items that do not meet that standard, such as certain high-caloric oral nutritional supplements, could still be covered when a provider specifically recommends them to meet a patient’s medical needs. The press release said the food and produce benefit under Special Supplemental Benefits for the Chronically Ill was used about 40 million times by chronically ill enrollees in 2025.
The proposed 10-year ADVaNCE MA model would begin in 2029 with a pre-implementation period starting June 8, 2027, and would operate in randomly selected states, the fact sheet says. CMS describes it as the Innovation Center’s first mandatory MA model. It would include a shadow test of an inferred risk adjustment model using Medicare claims, encounter and enrollment data; a localized Diamond Ratings System to replace Star Ratings in select states; and new flexibilities for low-income subsidy enrollees to receive healthy food, transportation and caregiver support. CMS is thinking about, but not yet proposing, a dialysis carveout for beneficiaries with end-stage renal disease.
CMS would refocus the Star Ratings program on 15 measures, with a focus on clinical outcomes and patient experience along with a few process measures where performance is low. The agency proposes dropping the reward factor and adjusting the hold harmless methodology to apply only to contracts rated 4.5 stars or higher. The measure removals would be effective for the 2028 measurement period and the 2030 Star Ratings.
To ease market entry, the proposal shifts network adequacy review from the Medicare Advantage application to the first operational year in a new or expanded service area. It would merge the clinical psychology, clinical social work, and outpatient behavioral health specialty types into one, and raise the telehealth credit beyond the current 10 percentage points. CMS also proposes an enrollment capacity limit process and a special enrollment period for people whose chosen plan is at capacity.
For special needs plans, CMS proposes requiring chronic condition and certain institutional plans with at least 60 percent dually eligible individuals to coordinate with Medicaid across settings. The rule would amend the fully integrated dual eligible special needs plan definition so the Medicare and Medicaid contracts no longer need to be held by the same legal entity, and expand the highly integrated D-SNP definition to recognize additional contractual affiliations.
CMS proposes eliminating its defined compensation caps and renewal limits for agents and brokers, along with referral fee caps and duplicative training and reporting requirements. The agency would instead use market-based guardrails, identify compensation outliers and permit compensation changes during the plan year with advance notice.
For Part B drugs selected for maximum fair price negotiation, the rule would require Medicare Advantage contracts to require providers to enroll in the Medicare Transaction Facilitator Data Module. MA organizations would submit encounter data records within 30 days and collect 11-digit National Drug Codes, and out-of-network cost sharing would be calculated at or below the maximum fair price.
The press release said the rule will accept public comments for 60 days after Federal Register publication.
Sources: Centers for Medicare and Medicaid Services (1, 2)
Corrections. Report an error to corrections@clinicalobserver.com. Read our corrections policy.